Enveric Biosciences (ENVB) has appointed Carter Ward as CFO, effective May 15th, 2021. He is replacing John Van Buiten. Prior to joining the company, Ward most recently served as CFO at Elite Pharmaceuticals. John Van Buiten is expected to remain in a consulting role with the company.
"Since becoming a public company in late-December 2020, Enveric has already achieved notable strategic milestones, working diligently to execute its vision of bringing new-generation, naturally occurring and synthetic compounds to cancer patients who need better, safer supportive care treatments," said Ward.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.